Sort
25,944 grants matching “neurodegeneration”
Understand and probing disrupted glucose metabolism in Alzheimer's disease
$3,597,332Ken Nakamura · J. David Gladstone Institutes · RF1 · FY2019 · AG
A systems approach to uncover upstream activators and common downstream pathways of neurodegeneration in a Drosophila model
$3,588,826Joshua T Dubnau · State University New York Stony Brook · RF1 · FY2017 · AG
Mitochondrial stress responses in neurodegeneration
$3,579,644Derek Narendra · National Institute Of Neurological Disorders And Stroke · ZIA · FY2025 · NS
Antisense oligonucleotide treatment of Ataxia-Telangiectasia IND#144349 IND/IDE April 19, 2024
$3,577,616Timothy Wei-Wen Yu · Boston Children'S Hospital · R01 · FY2025 · FD
Center without Walls for Imaging Proteinopathies with PET (CW2IP2)
$3,573,953Robert H Mach · University Of Pennsylvania · U19 · FY2019 · NS
Subclinical Vascular Contributions to Alzheimer's Disease: The Multi Ethnic Study of Atherosclerosis (MESA) Multisite Studyof AD
$3,573,149Timothy M. Hughes · Wake Forest University Health Sciences · R01 · FY2019 · AG
Targeted disruption the enzymes of O-GlcNAc cycling: Animal models of Disease
$3,566,145John A. Hanover · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2021 · DK
Study to Uncover Pathways to Exceptional Cognitive Resilience in Aging (SUPERAging)
$3,562,822Emily J Rogalski · University Of Chicago · U19 · FY2024 · AG
Neurodegeneration in Aging Down Syndrome (NiAD): A Longitudinal Study of Cognition and Biomarkers of Alzheimer's Disease
$3,556,865Benjamin L Handen · University Of Pittsburgh At Pittsburgh · U01 · FY2016 · AG
Acetyl-CoA flux and mitochondrial adaptation: a pathogenic role in aging and AD?
$3,544,415Luigi Puglielli · University Of Wisconsin-Madison · RF1 · FY2017 · AG
PET Radiopharmaceutical Sciences
$3,529,636Victor W Pike · National Institute Of Mental Health · Z01 · FY2007 · MH
SARS-CoV-2 and Precursors of Alzheimer's Disease and Related Dementias: An Ultrahigh Field (7T) MRI Study in a Diverse Multinational Cohort
$3,529,440Sudha Seshadri · University Of Texas Hlth Science Center · R56 · FY2021 · AG
Escitalopram for Agitation in Alzheimer Disease
$3,521,438Constantine G Lyketsos · Johns Hopkins University · R01 · FY2021 · AG
Functional Imaging of The Brain
$3,515,629Alan Koretsky · National Institute Of Neurological Disorders And Stroke · ZIA · FY2021 · NS
Towards a comprehensive signaling pathway map of parahippocampal vulnerability in Alzheimers Disease
$3,514,658Bin Zhang · Icahn School Of Medicine At Mount Sinai · RF1 · FY2017 · AG
Sphingolipid Biology of Neurodegeneration
$3,503,685Richard Proia · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2024 · DK
Dominantly Inherited Alzheimer Network
$3,495,735Randall J Bateman · Washington University · UF1 · FY2017 · AG
The Neighborhoods Study: Contextual Disadvantage and Alzheimerâs Disease and Related Dementias (ADRD)
$3,494,004Amy J. Kind · University Of Wisconsin-Madison · R01 · FY2023 · AG
Massachusetts Alzheimer's Disease Research Center
$3,486,460Bradley T Hyman · Massachusetts General Hospital · P30 · FY2020 · AG
The VETSA Longitudinal Twin Study of Cognition and Aging (VETSA 4)
$3,468,641Matthew S Panizzon · University Of California, San Diego · R01 · FY2024 · AG
Diabetes and brain amyloid in middle aged Hispanics
$3,467,959Jose A Luchsinger · Columbia University Health Sciences · R01 · FY2024 · AG
Vanderbilt Memory & Aging Project
$3,463,466Angela L. Jefferson · Vanderbilt University Medical Center · R01 · FY2023 · AG
Vanderbilt Memory & Aging Project
$3,449,700Angela L. Jefferson · Vanderbilt University Medical Center · R01 · FY2024 · AG
Identification and characterization of tau seeding and strain composition in tauopathy
$3,442,490Marc I Diamond · Ut Southwestern Medical Center · RF1 · FY2019 · AG
The VETSA Longitudinal Twin Study of Cognition and Aging (VETSA 4)
$3,441,898William S Kremen · University Of California, San Diego · R01 · FY2020 · AG